Product
Metformin≥1000mg
1 clinical trial
1 indication
Indication
Type 2 DiabetesClinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase III Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or Pioglitazone 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and DapagliflozinStatus: Completed, Estimated PCD: 2022-09-19